CN105878905A - 治疗高血压、冠心病、中风和免疫力低下的中药组合物 - Google Patents
治疗高血压、冠心病、中风和免疫力低下的中药组合物 Download PDFInfo
- Publication number
- CN105878905A CN105878905A CN201610415031.2A CN201610415031A CN105878905A CN 105878905 A CN105878905 A CN 105878905A CN 201610415031 A CN201610415031 A CN 201610415031A CN 105878905 A CN105878905 A CN 105878905A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- apoplexy
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 50
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 44
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 36
- 206010008190 Cerebrovascular accident Diseases 0.000 title claims abstract description 33
- 208000006011 Stroke Diseases 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 208000033065 inborn errors of immunity Diseases 0.000 title claims abstract description 20
- 208000028529 primary immunodeficiency disease Diseases 0.000 title claims abstract description 20
- 241000222336 Ganoderma Species 0.000 claims abstract description 17
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000141331 Amomum villosum Species 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000218231 Moraceae Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241001619444 Wolfiporia cocos Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 67
- 210000004369 blood Anatomy 0.000 description 63
- 210000003734 kidney Anatomy 0.000 description 29
- 210000004185 liver Anatomy 0.000 description 28
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 210000001835 viscera Anatomy 0.000 description 22
- 201000010099 disease Diseases 0.000 description 21
- 210000002216 heart Anatomy 0.000 description 19
- 230000007812 deficiency Effects 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 15
- 239000003172 expectorant agent Substances 0.000 description 14
- 230000003419 expectorant effect Effects 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 13
- 230000001737 promoting effect Effects 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 230000036772 blood pressure Effects 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 9
- 230000004087 circulation Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 206010000077 Abdominal mass Diseases 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 206010002383 Angina Pectoris Diseases 0.000 description 5
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 5
- 230000036528 appetite Effects 0.000 description 5
- 235000019789 appetite Nutrition 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010008132 Cerebral thrombosis Diseases 0.000 description 4
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 230000023555 blood coagulation Effects 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000035487 diastolic blood pressure Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 208000037920 primary disease Diseases 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000000115 thoracic cavity Anatomy 0.000 description 4
- 210000004026 tunica intima Anatomy 0.000 description 4
- 239000011800 void material Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 206010061216 Infarction Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000001647 Renal Insufficiency Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 230000003862 health status Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000007574 infarction Effects 0.000 description 3
- 201000006370 kidney failure Diseases 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 235000021395 porridge Nutrition 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010012373 Depressed level of consciousness Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000031975 Yang Deficiency Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000003116 impacting effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000358 Accelerated hypertension Diseases 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000003028 Stuttering Diseases 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 208000015606 cardiovascular system disease Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000013551 empirical research Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000037890 multiple organ injury Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000003955 neuronal function Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 206010029446 nocturia Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000018316 severe headache Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种治疗高血压、冠心病、中风和免疫力低下的中药组合物,包括按重量份计的下述组分:红景天5‑7份、黄芪3‑5份、灵芝3‑5份、阳春砂仁1‑3份、茯苓1‑3份、杜仲5‑7份、桑椹1‑3份、白芍2‑4份、丹参3‑5份和西红花0.5‑1份。该组合物在治疗高血压的同时能治疗冠心病、中风、免疫力低下,其药效明确、疗效稳定可靠、无毒副作用,能有效地控制或治愈病情。
Description
技术领域
本发明属于中药技术领域,具体涉及一种治疗高血压、冠心病、中风、免疫力低下的中药组合物及其制备方法。
背景技术
现代医学研究表明,人在年轻时,血液质量及血管的通透性好,随着年龄的增长生理机能生理性减退和生活方式的错误导致体内毒素的积累,有毒的废物和脂肪质黏附在血管内而阻碍血液的畅通,血液中的脂质沉着在原本光滑的血管内膜上,在血管内膜一些类似粥样的脂类物质堆积而成白色斑块,血管硬化,这些斑块渐渐增多造成血管腔狭窄,使血流受阻,血管硬化导致高血压,心脏缺血,产生心绞痛。如果动脉壁上的斑块形成溃疡或破裂,就会形成血栓,使整个血管血流完全中断,发生在心脏导致心肌梗塞,甚至猝死。发生在脑形成脑血栓,硬化的血管易破,如受高压冲击,血管破裂就出现脑出血。下面分别详述组方治疗高血压、冠心病、中风、免疫力低下。
高血压的病根主要原因是血液、血管受损,99.9%的高血压病人都伴有微小血管损伤。高血压是引起脑溢血、心力衰竭和肾功能衰竭三大并发症的罪魁祸首。虽然现在已有许多西药具有降压作用,可以控制血压,但降压西药对心、脑、肝、肾均有毒副作用,被称为“高血压并发症的催化剂和帮凶”,因而降压西药也是一把双刃剑,一方面控制血压,另一方面也在毒害生命。而高血压病人本身心、脑、肝、肾已经受到高血压的损害,为了降压,西药又必须长期服用,这样两毒相加,雪上加霜,恶性循环下去导致心、脑、肾等多脏器损伤,从而导致高血压、冠心病、中风、肾功能不全等多病同发,严重损害人类身体健康。
高血压的症状因人而异。早期可能无症状或症状不明显,仅仅会在劳累、精神紧张、情绪波动后发生血压升高,并在休息后恢复正常。随着病程延长,血压明显的持续升高,逐渐会出现各种症状。此时被称为缓进型高血压病。缓进型高血压病常见的临床症状有头痛、头晕、注意力不集中、记忆力减退、肢体麻木、夜尿增多、心悸、胸闷、乏力等。当血压突然升高到一定程度时甚至会出现剧烈头痛、呕吐、心悸、眩晕等症状,严重时会发生神志不清、抽搐。这就属于急进型高血压和高血压危重症,多会在短期内发生严重的心、脑、肾等器官的损害和病变,如中风、心梗、肾衰等。症状与血压升高的水平并无一致的关系。
冠心病,是一种最常见的心脏病,由于脂质代谢异常,血液中的脂质沉着在原本光滑的动脉内膜上,在动脉内膜一些类似粥样的脂类物质堆积而成白色斑块,这些斑块渐渐增多造成动脉腔狭窄,使血流受阻,导致心脏缺血,产生心绞痛。如果动脉壁上的斑块形成溃疡或破裂,就会形成血栓,使整个血管血流完全中断,发生急性心肌梗死,甚至猝死。冠心病属于中医“胸痹”、“心痛”、“真心痛”的范畴。中医认为本病的病位在心,是一种本虚标实、虚实夹杂的疾病。气滞、血瘀、痰浊、寒凝、正气不足是其主要的发病因素,但心与肺、肝、脾、肾关系密切,四脏功能失调会影响到心主血脉之功能,导致气血运行不畅,不通则痛。
《金匮要略》云:“阳微阴弦,即胸痹而痛,所以然者,责其极虚也。”“阳微”是上焦阳虚,“阴弦”是指阴寒太甚或上焦阳虚,则必有心气悸动,温煦不力,心不主血再加阴寒凝滞血脉,必有瘀血产生。《医门法律》云:“胸痹总因阳虚,故阴得乘之。”阐明本病与脏腑虚损、气血阴阳不足有关。宋《太平惠民圣方》“胸痹疼痛,痰逆于胸,心膈不利”,为痰论的重要发展。随着物质生活水平的提高,饮食结构的的变化,高脂肪、高蛋白、高热量食物摄入过多,高脂血症患者增多。因冠心病患者血液多呈现浓、粘、聚、凝的病理特点,故有学者认为本病是由于痰瘀互结、损伤心络的结果,提出冠心病应从痰论治,痰浊夹瘀时应痰瘀同治,痰浊挟虚时应化痰补虚。此是本病实证研究的一方面;虚证则侧重于与五脏的关系。有研究认为胸痹中医病机中气滞等同于冠脉痉挛;血瘀等同于血液流变学异常;痰浊等同于冠脉管壁斑块形成;冠心病的中医病理变化由气滞、血瘀、痰浊互结自轻而重发展,与西医冠脉病变程度、心梗、心功能异常在一定程度上存在着一致性。
中风,又称脑卒中,现代医学研究表明,随着年龄的增长生理机能生理性减退和生活方式的错误导致体内毒素的积累,有毒的废物和脂肪质黏附在血管内而阻碍血液的畅通,血液中的脂质沉着在原本光滑的血管内膜上,在血管内膜一些类似粥样的脂类物质堆积而成白色斑块,血管硬化,这些斑块渐渐增多造成血管腔狭窄,使血流受阻,如果动脉壁上的斑块形成溃疡或破裂,就会形成血栓,使整个血管血流完全中断,发生在脑形成脑血栓;硬化的血管易破,如受高压冲击,血管破裂就出现脑出血。
中风(脑血栓或脑出血)是一组以急性起病,局灶性或弥漫性神经功能缺损为共同特征,以半身不遂,口舌斜,言语謇涩为主要临床表现,或伴有神志不清的脑血管病,其死亡率高、致残率高,给家庭和社会带来了沉重的负担。据有关资料统计,随着人们生活方式的改变,我国已成为这类疾病的高发地区,西医主要采用通过扩血管、降低血液粘稠度、降脂,增强缺血缺氧脑组织的血液供应及促进“半暗带”内存活的神经元功能恢复等方法治疗,不能够完全根治,有明显的用药副作用,并且治疗费用昂贵。
免疫力是人体自身的防御机制,是人体识别和消灭外来侵入的任何异物(病毒、细菌等);处理衰老、损伤、死亡、变性的自身细胞以及识别和处理体内突变细胞和病毒感染细胞的能力。免疫力低下的身体易于被感染或患癌症;各种原因使免疫系统不能正常发挥保护作用,在此情况下,极易招致细菌、病毒、真菌等感染,因此免疫力低下最直接的表现就是容易生病。因经常患病,加重了机体的消耗,所以一般有体质虚弱、营养不良、精神萎靡、疲乏无力、食欲降低、睡眠障碍等表现,生病、打针吃药便成了家常便饭。每次生病都要很长时间才能恢复,而且常常反复发作。长此以往会导致身体和智力发育不良,还易诱发重大疾病。
我国作为传统中医药大国,在治疗高血压方面也积累了丰富的经验,近年来传统的中医公开了多种配方,治疗高血压的偏方配方均各不相同,治疗效果也不尽相同,但现今高血压发病大都同时或后期一并伴有冠心病,中风,免疫力低下等疾病。在治疗高血压的同时能治疗冠心病,中风,免疫力低下的药还没有,治病未防病,治病未治根,病去又再来。
发明内容
本发明的目的是提供一种在治疗高血压的同时能治疗冠心病、中风、免疫力低下的中药组合物及其制备方法,其药效明确、疗效稳定可靠、无毒副作用,能有效地控制或治愈病情。
本发明的技术方案为:一种治疗高血压、冠心病、中风和免疫力低下的中药组合物,包括按重量份计的下述组分:红景天5-7份、黄芪3-5份、灵芝3-5份、阳春砂仁1-3份、茯苓1-3份、杜仲5-7份、桑椹1-3份、白芍2-4份、丹参3-5份和西红花0.5-1份。
在一个具体实施例中,各组分重量份为:红景天5份、黄芪5份、灵芝3份、阳春砂仁2份、茯苓2份、杜仲5份、桑椹2份、白芍3份、丹参3份和西红花0.5份。
在一个具体实施例中,各组分重量份为:红景天6份、黄芪3份、灵芝3份、阳春砂仁2份、茯苓2份、杜仲6份、桑椹2份、白芍3份、丹参4份和西红花0.7份。
在一个具体实施例中,各组分重量份为:红景天7份、黄芪4份、灵芝4份、阳春砂仁2份、茯苓2份、杜仲7份、桑椹2份、白芍3份、丹参4份和西红花1份。
上述中药组合物的制备方法,将所述原料混合粉碎,用开水密封浸泡20~30分钟并滤去药粉制成。
进一步的,将所述原料粉碎成100目的药粉。
进一步的,每克药粉加入20~30mL的开水。
本发明还提供所述中药组合物在制备治疗高血压、冠心病、中风和免疫力低下的药物中的应用。
本发明中各原料的作用机理:
红景天,甘、苦,平。归肺、心经。益气活血,通脉平喘。用于气虚血瘀,胸痹心痛,中风偏瘫,倦怠气喘。
黄芪,甘,微温。归肺、脾经。补气升阳,固表止汗,利水消肿,生津养血,行滞通痹,托毒排脓,敛疮生肌。用于气虚乏力,食少便溏,中气下陷,久泻脱肛,便血崩漏,表虚自汗,气虚水肿,内热消渴,血虚萎黄,半身不遂,痹痛麻木,痈疽难溃,久溃不敛。
灵芝,甘,平。归心、肺、肝、肾经。补气安神,止咳平喘。用于心神不宁、失眠心悸,肺虚咳喘,虚劳短气,不思饮食。
阳春砂仁,辛,温。归脾、胃、肾经。化湿开胃,温脾止泻,理气安胎。用于湿浊中阻,脘痞不饥,脾胃虚寒,呕吐泄泻,妊娠恶阻,胎动不安。
茯苓,甘、淡,平。归心、肺、脾、肾经。利水渗湿,健脾,宁心。用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。
桑椹,甘、酸,寒。归心、肝、肾经。滋阴补血,生津润燥。用于肝肾阴虚,眩晕耳鸣,心悸失眠,须发早白,津伤口渴,内热消渴,肠燥便秘。
杜仲,甘,温。归肝、肾经。补肝肾,强筋骨,安胎。用于肝肾不足,腰膝酸痛,筋骨无力,头晕目眩,妊娠漏血,胎动不安。从祖国医学角度分析,杜仲能入肝补肾,其既有补阳作用,又兼有滋阴作用,故对阴阳两虚及阴虚阳亢、头晕目眩、耳鸣心悸、腰腿酸痛、夜尿多、失眠多梦有治疗作用。现代医学认为,高血压所产生的一些主要症状,属心血管系统或神经系统疾病。根据现代药理学研究证明,杜仲主要通过减少或改善血管损伤、改善脑、肝、肾等脏器的循环而起作用。临床观察中发现,多数患者在降压效果出现之前,首先表现为头昏减轻,精神振作,身轻体健,特别是老年妇女,更为明显。因此,杜仲尚有调节内分泌功能。
丹参,苦,微寒。归心、肝经。活血祛瘀,通经止痛,清心除烦,凉血消痈。用于胸痹心痛,脘腹胁痛,瘕瘕积聚,热痹疼痛,心烦不眠,月经不调,痛经经闭,疮疡肿痛。
白芍,苦、酸,微寒。归肝、脾经。养血调经,敛阴止汗,柔肝止痛,平抑肝阳。用于血虚萎黄,月经不调,自汗,盗汗,胁痛,腹痛,四肢挛痛,头痛眩晕。
西红花,甘,平。归心、肝经。活血化瘀,凉血解毒,解郁安神。用于经闭瘕瘕,产后瘀阻,温毒发斑,忧郁痞闷,惊悸发狂。
组方药效入五脏,达六腑,能益气化瘀,清血生血,解郁宁神,护正固本,补五脏之精气,泄六腑之糟粕,补而不滞,行而不破,五脏得到清修补,六腑得以排泄清,五脏平而精气盛,六腑清而身体轻。阴阳平衡病自去,正气存内免疫强。组方通过桑椹补肾之阴血以补肾阴,肾血;杜仲、灵芝,补肾之阳以补肾气、肾阳。肾之气血阴阳得以补,肾精充盛先天足,人之根本得以固。组方通过西红花、丹参、白芍、桑椹、杜仲、灵芝,清肝中血热以降肝火,舒肝之郁气以化肝郁,行肝之藏血以化肝瘀,补肝之气血以补肝。达到清肝,疏肝,补肝之功效。组方阳春砂辛温开胃,振奋脾阳;加红景天,黄芪补气扶正,使脾阳之气得以迅速提升;茯苓利水渗湿,健脾宁心。二者合用升阳降浊,使后天摄入水谷转化之精微升肺而输布全身,转化后痰浊糟粕随二便而排出,脾胃强健,血源得清。黄芪、红景天、灵芝,大补五脏之阳气,使体内气血运行通畅。丹参、西红花,活血化瘀,清热解毒,使血清而不滞。血清,气畅,精旺,五脏精满正气足,正气存内,邪不可干。组方、药量、药物性味均配比科学。
高血压,中医认为:肾虚、肝淤、血凝,气滞是高血压的病因,其病变在肝,病源在肾。组方科学配比,能迅速补肾虚、清肝淤、化血凝,行气滞,从而能持久地降压,并从根本上治疗好高血压。
冠心病,中医认为本病的病位在心,是一种本虚标实、虚实夹杂的疾病。气滞、血瘀、痰浊、寒凝、正气不足是其主要的发病因素,但心与肺、肝、脾、肾关系密切,四脏功能失调会影响到心主血脉之功能,导致气血运行不畅,不通则痛。组方科学配比,黄芪、红景天、灵芝,大补五脏之阳气,使体内气血运行通畅。迅速补正气,行气,温阳;丹参、西红花,活血化瘀,清热解毒,使血清而不滞,速化血瘀;阳春砂辛温开胃,振奋脾阳,茯苓利水渗湿,健脾宁心,二者合用升阳降浊,使后天摄入水谷转化之精微升肺而输布全身,转化后痰浊糟粕随二便而排出,脾胃强健,血源得清,痰浊立化。组方能迅速补肾虚、清肝淤。五脏得到清修补,六腑得以排泄清,五脏平而精气盛,六腑清而身体轻。组方通过迅速行气,化瘀,化痰,温阳,补正气。从而能持久地治疗气滞、血瘀、痰浊、寒凝、正气不足,从根本上治疗好冠心病。
中风,中医认为:肾虚、脑淤、血凝,血热、气滞是中风的病因,其病变在脑,病源在肝、肾。组方科学配比,能迅速补肾虚、清脑淤、化血凝、清血热、行气滞,从而能持久地治疗中风,并从根本上治疗好中风。
免疫力低下,组方药效入五脏,达六腑,能益气化瘀,清血生血,解郁宁神,护正固本,补五脏之精气,泄六腑之糟粕,补而不滞,行而不破,五脏得到清修补,六腑得以排泄清,五脏平而精气盛,六腑清而身体轻。阴阳平衡病自去,正气存内免疫强。
与现有技术相比,本发明的有益效果是:在治疗高血压的同时能治疗冠心病、中风、免疫力低下等多种疾病,能有效地控制或治愈病情。配方经4年400例病人一个疗程(一个月)到24个疗程(24个月)临床口服,未发现毒性及明显副作用。配方科学配比,能从根本上治好病,疗效好,无副作用,口感适中,原药材价格低,来源广泛,且一药治疗多钟病,明显减少了用药品种,降低了多药同用的副作用,及有效降低了治病成本。本配方组方完全符合中医治病的整体观,“阴平阳秘”,“正气存内,邪不可干”,具有广泛的实用性。如果配方制成药品通过一带一路走出出,将具有广阔的发展前景,值得推广应用。
具体实施方式
实施例一
取干净、干燥的红景天5份、黄芪5份、灵芝3份、阳春砂仁2份、茯苓2份、杜仲5份、桑椹2份、白芍3份、丹参3份和西红花0.5份。
将上述药均匀混合,用中药粉粹机粉成100目的药粉。
将上述药粉分成7.5g一个小包装,450g一个中包装,二个小包装15g为一天的用量,60个小包装共450g是一个中包装为一个月的用量。
实施例二
取干净、干燥的红景天6份、黄芪3份、灵芝3份、阳春砂仁2份、茯苓2份、杜仲6份、桑椹2份、白芍3份、丹参4份和西红花0.7份。制备方法如实施例一。
实施例三
取干净、干燥的红景天7份、黄芪4份、灵芝4份、阳春砂仁2份、茯苓2份、杜仲7份、桑椹2份、白芍3份、丹参4份和西红花1份。制备方法如实施例一。
临床病例研究:
根据2010年中国高血压防治指南血压水平诊断标准确诊如下高血压及其并发症患者,其中一级高血压65例,二级高血压73例,三级高血压55例,冠心病心绞痛65例,冠心病心肌梗塞55例,冠心病2度心衰50例,中风后遗症105例,脑血栓及脑梗塞55例,脑出血50例,高血压并冠心病120,高血压并中风85例,中风兼冠心病52例,高血压、冠心病、并中风45例,免疫力低下48例。
治疗方法:根据血压分级的不同,服用本实施例一制备的中药制剂1~6个疗程。每次取7.5g(一小袋)药粉用100度的开水200ml装在密封保温杯内摇匀浸泡20~30分钟后取上面的药液口服,只服药液不服药粉;再续用100度的开水200ml摇匀药液浸泡20-30分钟后又取上面的药液口服,上午服二次;下午用同样的方法再服二次,一个月为一个疗程。
高血压疗效判断标准:
显效:①舒张压下降10mmHg以上,并达到正常范围;②舒张压虽未降至正常但已下降20mmHg或以上;
有效:①舒张压下降不及10mmHg,但已达正常范围;②舒张压较服用本发明中药制剂前下降10~19mmHg,但未达到正常范围;③收缩压较治疗前下降30mmHg以上,须具备其中1项;
无效:未达到以上标准。
冠心病疗效判断标准:
显效:①冠心病各症状明显减轻,达到健康状态;②冠心病各症状明显减轻,但未达到健康状态;
有效:冠心病各症状稍有缓解,未达健康状况;
无效:冠心病各症状无变化。
中风后遗症疗效判断标准:
显效:①血糖、尿糖测定,服药后血糖、尿糖症状明显减轻,达到正常范围;②嗜酸细胞数目服药后有明显增多,达到正常范围;③脑CT扫描诊断,服药后诊断结果无中风病症;
有效:①血糖、尿糖测定,服药后血糖、尿糖症状稍有缓解,未达到正常范围;②嗜酸细胞数目服药后略微增多,未达到正常范围;
无效:中风后遗症病症无任何改善。
治疗效果统计结果,如下表。
显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
Claims (8)
1.一种治疗高血压、冠心病、中风和免疫力低下的中药组合物,其特征在于包括按重量份计的下述组分:红景天5-7份、黄芪3-5份、灵芝3-5份、阳春砂仁1-3份、茯苓1-3份、杜仲5-7份、桑椹1-3份、白芍2-4份、丹参3-5份和西红花0.5-1份。
2.根据权利要求1所述的治疗高血压、冠心病、中风和免疫力低下的中药组合物,其特征在于各组分重量份为:红景天5份、黄芪5份、灵芝3份、阳春砂仁2份、茯苓2份、杜仲5份、桑椹2份、白芍3份、丹参3份和西红花0.5份。
3.根据权利要求1所述的治疗高血压、冠心病、中风和免疫力低下的中药组合物,其特征在于各组分重量份为:红景天6份、黄芪3份、灵芝3份、阳春砂仁2份、茯苓2份、杜仲6份、桑椹2份、白芍3份、丹参4份和西红花0.7份。
4.根据权利要求1所述的治疗高血压、冠心病、中风和免疫力低下的中药组合物,其特征在于各组分重量份为:红景天7份、黄芪4份、灵芝4份、阳春砂仁2份、茯苓2份、杜仲7份、桑椹2份、白芍3份、丹参4份和西红花1份。
5.一种权利要求1~4之一所述中药组合物的制备方法,其特征在于将所述原料混合粉碎,用开水密封浸泡20~30分钟并滤去药粉制成。
6.根据权利要求5所述的中药组合物的制备方法,其特征在于将所述原料粉碎成100目的药粉。
7.根据权利要求6所述的中药组合物的制备方法,其特征在于每克药粉加入20~30mL的开水。
8.一种权利要求1~4之一所述中药组合物在制备治疗高血压、冠心病、中风和免疫力低下的药物中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610415031.2A CN105878905A (zh) | 2016-06-15 | 2016-06-15 | 治疗高血压、冠心病、中风和免疫力低下的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610415031.2A CN105878905A (zh) | 2016-06-15 | 2016-06-15 | 治疗高血压、冠心病、中风和免疫力低下的中药组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105878905A true CN105878905A (zh) | 2016-08-24 |
Family
ID=56729388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610415031.2A Pending CN105878905A (zh) | 2016-06-15 | 2016-06-15 | 治疗高血压、冠心病、中风和免疫力低下的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105878905A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113499397A (zh) * | 2021-09-02 | 2021-10-15 | 北京贡源本草生物科技有限公司 | 一种治疗冠心病的组合物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142952A (zh) * | 1994-12-17 | 1997-02-19 | 李高寅 | 灵芝口服液及其制备方法 |
CN101015632A (zh) * | 2006-02-07 | 2007-08-15 | 孙辅 | 一种治疗冠心病的药物及其制备方法 |
CN102743578A (zh) * | 2012-07-04 | 2012-10-24 | 乔振国 | 一种活血通络中药制剂 |
-
2016
- 2016-06-15 CN CN201610415031.2A patent/CN105878905A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142952A (zh) * | 1994-12-17 | 1997-02-19 | 李高寅 | 灵芝口服液及其制备方法 |
CN101015632A (zh) * | 2006-02-07 | 2007-08-15 | 孙辅 | 一种治疗冠心病的药物及其制备方法 |
CN102743578A (zh) * | 2012-07-04 | 2012-10-24 | 乔振国 | 一种活血通络中药制剂 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113499397A (zh) * | 2021-09-02 | 2021-10-15 | 北京贡源本草生物科技有限公司 | 一种治疗冠心病的组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101254272B (zh) | 一种活血通脉抗栓塞的药物 | |
CN104146261B (zh) | 一种妇女更年期的中药保健品及其制备方法 | |
CN101966271A (zh) | 一种治疗高血压的中药汤剂 | |
CN103211930B (zh) | 一种降血脂、降血压的中药制剂 | |
CN104758806A (zh) | 一种治疗冠心病的煎膏剂及其制备方法 | |
CN101804110B (zh) | 一种抗血栓和降血脂的中药制剂 | |
CN105106446A (zh) | 一种用于降血压的保健茶及其制备方法 | |
CN104522213A (zh) | 适宜三高人群饮用的茶饮及其制备方法 | |
CN101229345B (zh) | 益气补血药 | |
CN103908652A (zh) | 一种治疗失眠的足浴中药及其制备方法 | |
CN109674912A (zh) | 一种调理痰湿体质的中药泡浴抑菌液/颗粒及制备与使用方法 | |
CN105878905A (zh) | 治疗高血压、冠心病、中风和免疫力低下的中药组合物 | |
CN101317916B (zh) | 一种治疗崩漏的药剂及其制备方法 | |
CN103751679A (zh) | 一种治疗肝肾阴虚型高脂血症的中药制备方法 | |
CN104172166B (zh) | 一种适用于ⅱ型糖尿病人产后的保健粥及其制备方法 | |
CN103920102A (zh) | 一种治疗原发性低血压的中药药物 | |
CN102579688B (zh) | 菊麻降压中药制剂 | |
CN101085330A (zh) | 一种内服治疗高血脂的中药组合物 | |
CN104921242A (zh) | 一种减肥饮料及其制备方法 | |
CN104288503A (zh) | 一种益气补肾的中药酒 | |
CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
CN104587345B (zh) | 一种治疗阿尔茨海默病的中药制剂及其制备方法 | |
CN101244209B (zh) | 预防或治疗心脑血管疾病的药物 | |
CN105832934A (zh) | 一种治疗高血压病的中药 | |
CN104645244A (zh) | 一种治疗动脉硬化症的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160824 |